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This daily COVID-19 Health Evidence Summary is to signpost DFID and other UK government 
departments to the latest relevant evidence and discourse on COVID-19 to inform and support 
their response. It is a result of 3 hours of work and is not intended to be a comprehensive summary 
of available evidence on COVID-19 but aims to make original documents easily accessible to 
decision makers which, if relevant to them, they should go to before making decisions.   





















 There is insufficient data to 
quantify all of the adverse 
effects that might reduce 
the acceptability, 
adherence and 
effectiveness of facemask 
 The downsides identified in 
this systematic review 
should aid approaches in 
mitigating problems (when, 
where and how of mask 
wearing or by mask 
redesign or substitution 
with alternatives such as 
face shields) and guide 
where the benefits of 
masks outweigh the 
downsides 
 New research on 
facemasks should also 
assess and report the 
harms and downsides 
 Research is also urgently 
required on methods and 
designs to mitigate 
downsides of facemask 






mask alternatives e.g. face 
shields 













 Presents a list of tools and 
entities to achieve 
maximum impact  
 The list is drawn from 
pandemic mitigation tools 
developed in response to 
past outbreaks including 
influenza, coronaviruses 
and Ebola 
 Highlights the role of 
political will, whole-of-
government approach, and 
the role of introducing 




Comments, Editorials, Opinions, Blogs, News 
Publication 
date 
Title/URL Journal | 
Article type 
Author(s) 





20.06.2020 Men’s health: COVID-19 pandemic highlights 
need for overdue policy action 






20.06.2020 Global governance for COVID-19 vaccines The Lancet | 
Editorial 
  
18.06.2020 Humanitarian financing is failing the COVID-19 
frontlines 




18.06.2020 Women and girls are leading the way towards 
universal access to sexual and reproductive 
healthcare: will the global community follow? 
CGD | Blog Julia Kaufman 
3 
17.06.2020 Hydroxychloroquine arm of Solidarity Trial 
stops 
WHO | News   
16.06.2020 ‘We’ve got to be able to move more quickly.’ 




















  Diagnostics  Treatments   Vaccines 



























































  Sierra 
Leone 





US NIH  Our World 
in Data: C19 
Testing 




Our World in 
Data 






      
Global 5050   UK  IFPRI 
COVID-19 








  US  COVID-19 
Primer 




     NIH 
LitCovid 
 UKCDR       
Information 
is Beautiful 
     WHO 
COVID-19 
Database 
        
LSHTM               
HealthMap 
(cases) 




              
C19 Resource Hubs 









  Social 
Sciences 
WHO COVID-
19 pandemic  
Africa CDC Annals of 
Internal 
Medicine 
LSTM Stop TB 
Partnership 







  IDA 























g in low 
resource 
settings 




















Cochrane  Center for Global 
Development 



















Institute of Public 
Health 
    





Oxford Centre for 
Evidence-based 
Medicine 
    




 HEART     
UNESCO   NEJM  UKRI     
6 
UN WFP   Oxford 
University 
Press 
 Evidence Aid     
GOARN   PLoS  NIH     
EPI-WIN   SAGE 
journals 
IFPRI Resources 
and Analyses of 
C19 Impact 
    
World Bank   Science  Prevent 
Epidemics  
    
Our World in 
Data 
  Springer 
Nature 




  SSRN 
(Preprints)  
      












      
WorldPop           
Flowminder           
COVID-END           
Premise 
COVID-19 





GISAID           
Online learning & events 






role in COVID-19 
vaccine development 
and access 




Social, political, and 
public health factors 
fuelling the COVID19 
crisis in Brazil and 
Colombia 








Online course 1 hour WHO 
16.06.2020 Africa beyond COVID-
19 






Nursing in Times of 
Crisis 
Online course 2 weeks – 
2 hours per 
week 




WHO Academy and 
WHO Info mobile 
applications 






















Webinar 1 hour WHO & ISQua – Dr 
Shams Syed, Dr Peter 
Lachman, Dr Teri 
Rynolds & Dr Ed Kelley 




5 hours Johns Hopkins 






5 sessions 1h 30 International Initiative 











online brief with Dr 
David Nabarro 
Event 1h 4SD 
30.04.2020 Professor Chris 
Whitty’s Gresham 
lecture on COVID-19 




























the Novel Coronavirus 
Online 
learning 





































of Edinburgh & Royal 
College of Physicians 
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Rapid review methodology 
The rapid daily search for peer-reviewed literature is carried out through a PubMed search with the following 
keywords (“COVID-19” OR “severe acute respiratory syndrome coronavirus 2” OR “2019-nCoV” OR “SARS-CoV-
2” OR “2019nCoV” OR “coronavirus” ) AND (“Africa”) OR (“equity” OR “equities”) OR (“poverty”), restricted to 
articles published in the previous 2 to 3 days, in English. This is complemented by a search of the homepage of 
the following high-impact global health journals: The Lancet journals, New England Journal of Medicine, Nature, 
JAMA, Annals of Internal Medicine, Cochrane Reviews, BMJ Global Health, the PLoS journals and a Twitter 
search of their Twitter pages. A search also of preprints from bioRxiv and medRxiv. Please note that papers that 
have not been peer-reviewed are highlighted in red. All primary research papers that relate to the primary and 
secondary impacts of the COVID-19 response in LMICs, and disease control and health system responses are 
included. Articles related to tackling the secondary impacts on other sectors are not included. Additional 
commentaries, opinions, and commissioned pieces are selected based on relevance. 
The search for dashboards, guidelines, tools, editorials, comments, blogs, opinions and news is through the 
academic journals listed above, C19 resource hubs and following lead academics and professionals on Twitter. 
  
10 
About this report 
This daily COVID-19 health evidence summary (HES) is based on 3 hours of desk-based research. The 
summary is not intended to be a comprehensive summary of available evidence on COVID-19 but aims to make 
original documents easily accessible to decision makers which, if relevant to them, they should go to before 
making decisions. The HES are not intended to replace medical or professional advice and the researcher or the 
K4D consortium cannot be held responsible for any decisions made about COVID-19 on the basis of the HES 
alone. K4D services are provided by a consortium of leading organisations working in international development, 
led by the Institute of Development Studies (IDS), with Education Development Trust, Itad, University of Leeds 
Nuffield Centre for International Health and Development, Liverpool School of Tropical Medicine (LSTM), 
University of Birmingham International Development Department (IDD) and the University of Manchester 
Humanitarian and Conflict Response Institute (HCRI). 
This evidence summary was prepared for the UK Government’s Department for 
International Development (DFID) and its partners in support of pro-poor programmes. 
It is licensed for non-commercial purposes only. K4D cannot be held responsible for 
errors, omissions or any consequences arising from the use of information contained in 
this health evidence summary. Any views and opinions expressed do not necessarily 
reflect those of DFID, K4D or any other contributing organisation.  
© DFID - Crown copyright 2020. 
 
